Hou Po
Magnolia officinalis Rehd. et Wils.
Also known as: Magnolia bark(English) 厚朴(Chinese)
Kōboku厚朴 コウボク(JP also admits Magnolia obovata) Hubak厚朴 후박 Hậu phác(source species Magnolia officinalis var. biloba) Hou P'o
Updated October 23, 2026 · Not yet clinically reviewed
Safety at a glance
5 recorded drug interactions
Contraindications or side effects are listed
No toxicity grade is recorded. Most herbs in the catalogue carry none.
Traditional Chinese Medicine
- Category
- transforming dampness
- Temperature
- Warm
- Taste
- Bitter,Pungent
- Channels
- Spleen,Stomach,Lung,Large Intestine
Functions
Dries Dampness and Transforms Phlegm; Descends Qi and Relieves Distension; Moves Qi and Resolves Stagnation; Calms Wheezing
Traditional uses
Hou Po (magnolia bark) is a warm, bitter-pungent herb that moves Qi, dries Dampness, and descends rebellious Qi in the Stomach and Lung. It is a primary herb for abdominal fullness, distension, and obstruction from Qi stagnation and Dampness in the middle burner. Its descending action also calms Lung Qi to relieve cough and wheezing with chest fullness. Because it moves and dries, it must be used cautiously in Yin deficiency and is contraindicated in pregnancy without careful formulation.
Western herbalism
Properties: carminative, antispasmodic, sedative
Pharmacological effects
- Anti-emetic: Methanol extract of M. obovata bark (1 g/kg oral) was anti-emetic in frogs with copper sulphate-induced emesis; magnolol and honokiol were active at 20 mg/kg.
- Muscle relaxation: Magnolol (100 mg/kg i.p., mice) gave strong central muscle relaxation for 2 h; higher doses of magnolol/honokiol abolished righting reflex; magnolol inhibited chicken extensor reflex (antagonized by strychnine); both inhibited K+ and Ca++ contraction of rat aorta.
- Antiulcerative: Magnolol inhibited Shay pylorus-ligation and water-immersion stress ulcers, histamine-induced duodenal spasm, and stimulated gastric acid secretion in anesthetized rats.
- Central inhibitory: Ether extract (i.p., mice) reduced spontaneous activity, antagonized methamphetamine/apomorphine excitation, produced slow-wave EEG and raised brain serotonin; magnolol and honokiol were the depressant principles.
- Antimicrobial: Decoction active in vitro against S. aureus, Streptococcus hemolyticus, B. diphtheriae, B. subtilis, B. dysenteriae and skin fungi; prolonged survival of anthrax-infected guinea pigs; magnolol and honokiol bactericidal to Streptococcus mutans at 6.3 µg/ml, stronger than berberine.
- Antiplatelet: Magnolol and honokiol inhibited collagen-induced rabbit platelet aggregation with IC50 1.9 x 10^-6 M, about three times more potent than aspirin.
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 304.
Formulas using this herb
87 of 87 formulas
- Ban Xia Hou Po Tang 半夏厚朴汤 · 9.00000g · chief
- Bao Chan Wu You Fang 保产无忧方 · 2.10000g · assistant
- Bao Chan Wu You San · 2.00000g
- Bao Zhen Tang · 4.50000g
- Bu Huan Jin Zheng Qi San 不换金正气散 · deputy
- Bu Xu Tang · 60.00000g
- Chai Hu Da Yuan Yin 柴胡达原饮 · 4.50000g
- Chai Ping Tang 柴平汤 · 6.00000g
- Cheng Qi Yang Ying Tang 承气养营汤 · 9.00000g
- Chu Shi Wei Ling Tang 除湿胃苓汤 · 9.00000g
- Da Cheng Qi Tang 大承气汤 · 15.00000g · assistant
- Da He Zhong Yin 大和中饮 · 4.50000g
- Da Qi Qi Tang 大七气汤 · 90.00000g
- Da Yuan Yin 达原饮 · 3.00000g · chief
- Er Jia Jian Zheng Qi San 二加减正气散 · 6.00000g
- Fen Xiao Tang 分消汤 · 3.00000g
- Fu Fang Da Cheng Qi Tang 复方大承气汤
- Gan Sui Tong Jie Tang · 15.00000g
- Ge Gen Huo Xiang Shao Yao Tang 葛根藿香芍药汤
- Gui Zhi Jia Hou Po Xing Zi Tang 桂枝加厚朴杏子汤 · 6.00000g
- He Ji Ju Xiao Feng San · 6.00000g
- Hou Po Ma Huang Tang · 15.00000g
- Hou Po Qi Wu Tang 厚朴七物汤 · 15.00000g
- Hou Po San Wu Tang 厚朴三物汤 · 24.00000g · chief
- Hou Po Sheng Jiang Ban Xia Gan Cao Ren Shen Tang 厚朴生姜半夏甘草人参汤 · 125.00000g
- Hou Po Wen Zhong Tang 厚朴温中汤 · chief
- Hua Shi Huo Xiang Tang · 6.00000g
- Huang Lian Xiang Ru Yin 黄连香薷饮 · 3.00000g
- Huang Long Tang 黄龙汤 · 12.00000g · deputy
- Huo Po Xia Ling Tang 藿朴夏苓汤 · 3.00000g
- Huo Xiang Zheng Qi San 藿香正气散 · 6.00000g · assistant
- Huo Xue Shu Gan Tang · 9.00000g
- Jia Jian Cheng Qi Tang 加减承气汤
- Jia Jian Xiao Qing Long Tang 加减小青龙汤
- Jia Wei Gua Lou Xie Bai Tang 加味瓜蒌薤白汤
- Jia Wei Ping Wei San 加味平胃散
- Jia Wei Xiao Xian Xiong Tang 加味小陷胸汤 · 3.00000g
- Jie Gan Jian 解肝煎 · 4.50000g
- Jie Nue Qi Bao Yin 截疟七宝饮 · 6.00000g
- Jin Hong Tang 锦红汤 · 12.00000g
- Jin Huang San 金黄散 / 金黄膏 · 1000.00000g
- Jiu Wei Bing Lang Jia Wu Fu Tang 九味槟榔加吴茯汤
- Ju He Wan 橘核丸 · 6.00000g · assistant
- Lei Shi Xuan Tou Mo Yuan Fa 雷氏宣透膜原法 · 3.00000g
- Lian Po Yin 连朴饮 · 6.00000g · chief
- Liu He Tang 六和汤
- Ma Zi Ren Wan 麻子仁丸 · 9.00000g · assistant
- Ma Zi Run Chang Wan 麻子润肠丸
- Mu Xiang Shun Qi San · 6.00000g
- Pai Qi Yin 排气饮 · 3.00000g
- Ping Wei San 平胃散 · 9.00000g · deputy
- Qian Jin Nei Tuo San 千金内托散 · 3.00000g
- Qing Pi Tang 清脾汤 · assistant
- Qing Pi Yin 清脾饮
- San Hua Tang 三化汤
- San Jia Jian Zheng Qi San 三加减正气散 · 6.00000g
- San Ren Tang 三仁汤 · 6.00000g · assistant
- San Wu Xiang Ru Yin 三物香薷饮 · 8.00000g
- San Zi Jiang Qi Tang 三子降气汤
- Shao Yao Hou Po Tang 芍药厚朴汤
- Shao Yao Yi Yi Ren Tang 芍药薏苡仁汤
- Shen Mi Tang 神秘汤 · 6.00000g
- Shi Liu Wei Liu Qi Yin 十六味流气饮
- Shi Pi Yin 实脾饮 · 6.00000g · assistant
- Shi Wei Xiang Ru Yin 十味香薷饮
- Shun Qi Huo Xue Tang · 3.00000g
- Si Jia Jian Zheng Qi San 四加减正气散 · 6.00000g
- Si Qi Tang 四七汤 · 9.00000g
- Su Zi Jiang Qi Tang 苏子降气汤 · 6.00000g · deputy
- Wu Ji San 五积散
- Wu Jia Jian Zheng Qi San 五加减正气散 · 6.00000g
- Xiang Ru San 香薷散 · 6.00000g · assistant
- Xiang Sha Ping Wei San 香砂平胃散 · 6.00000g
- Xiang Sha Yang Wei Tang 香砂养胃汤 · 2.40000g
- Xiao Cheng Qi Tang 小承气汤 · 6.00000g
- Xiao He Zhong Yin 小和中饮 · 4.50000g
- Xiao San Tang Yi Hao 消散汤一号
- Xin Jia Xiang Ru Yin 新加香薷饮 · 6.00000g · deputy
- Xing Ren Hua Shi Tang 杏仁滑石汤 · 6.00000g
- Yi Jia Jian Zheng Qi San 一加减正气散 · 9.00000g
- Zha Qu Ping Wei San 楂曲平胃散 · 9.00000g
- Zhi Shi Xiao Pi Wan 枳实消痞丸 · 12.00000g · deputy
- Zhi Shi Xie Bai Gui Zhi Tang 枳实薤白桂枝汤 · 12.00000g · deputy
- Zhi Suo Er Chen Tang 枳缩二陈汤 · 2.40000g
- Zhi Zi Hou Po Tang 栀子厚朴汤 · 12.00000g
- Zhong Man Fen Xiao Tang 中满分消汤 · 15.00000g
- Zhong Man Fen Xiao Wan 中滿分消丸 · 30.00000g
Botanical
Magnolia officinalis is a deciduous tree in the Magnoliaceae, endemic to mountainous regions of central and southern China, where it grows in mixed broadleaved forests between 300 and 1,500 m elevation. Mature specimens reach 15-25 m tall with a straight trunk, ascending branches and a broad, rounded crown. The bark is smooth and pale grey on young trees, becoming thicker, fissured and brownish with age, and is strongly aromatic when cut. The large, alternate leaves are obovate to elliptic, 20-45 cm long, leathery, dark green above and pale glaucous beneath, often clustered toward the branch tips. In early summer the tree bears solitary, fragrant, cup-shaped flowers 10-15 cm across, with 9-12 fleshy, creamy-white tepals. The aggregate fruit is a long, cylindrical, cone-like structure of follicles that split to release scarlet, fleshy-coated seeds. Cultivated trees are typically harvested for medicinal bark after 15-20 years.
- Family
- Magnoliaceae
- Pharmaceutical name
- Cortex Magnoliae Officinalis
- Parts used
- bark
- Plant type
- tree
- Native region
- Guizhou, Hubei, Hunan, Sichuan, Zhejiang
Constituents
Magnolol
Biphenolic neolignan · Principal neolignan of the stem and root bark; the Chinese Pharmacopoeia requires magnolol plus honokiol to total not less than 2.0% of the dried bark
Positively modulates synaptic and extrasynaptic GABA-A receptors, which underlies the anxiolytic and sleep-promoting activity attributed to the bark, and is anti-inflammatory, antimicrobial and antispasmodic in preclinical models.
This drug is the bark. The flower bud of the same species is a separate item of materia medica, Hou Po Hua, whose magnolol and honokiol content is roughly an order of magnitude lower; evidence generated on bark extracts should not be read across to it.
Honokiol
Biphenolic neolignan · Second major neolignan, assayed jointly with magnolol to the 2.0% Pharmacopoeia minimum
An isomer of magnolol that also potentiates GABA-A receptor currents and shows anti-inflammatory, neuroprotective and antitumour activity in preclinical work; it is the more studied of the pair for anticancer and neuroprotective endpoints.
beta-Eudesmol
Sesquiterpene alcohol · Major component of the bark essential oil, which itself is a minor fraction of the drug
A volatile sesquiterpene contributing to the aromatic, qi-moving character of the bark; reported to affect gastrointestinal motility and neuromuscular transmission in preclinical models.
Magnocurarine
Quaternary benzylisoquinoline alkaloid · Trace alkaloid of the bark; substantially higher in some other Magnolia and Manglietia species used as substitutes
Structurally related to tubocurarine and carries the same curare-like neuromuscular blocking liability, which is the basis of regulatory caution about magnolia bark in infants and small children.
Levels in authentic Magnolia officinalis bark are low, and the concern is greatest where a related species with higher magnocurarine content has been supplied in its place.
Magnoflorine
Aporphine alkaloid · Minor alkaloid of the bark
One of several minor isoquinoline-type alkaloids identified in the bark by HPLC-ESI-MSn alongside magnocurarine and tembetarine; not a target of Pharmacopoeia assay and not a principal contributor to the drug's recognised actions.
Drug interactions
Benzodiazepines, Z-drugs, alcohol and other CNS depressants
Moderate · Additive sedation, impaired psychomotor performance · Evidence level: Probable
Magnolol and honokiol are positive modulators at synaptic and extrasynaptic GABA-A receptors, the same target class as benzodiazepines and Z-drugs, so co-administration is expected to be additive. Human data are limited to small trials of proprietary bark extracts on stress and sleep endpoints, so the size of the effect at decoction doses is not quantified.
Clinical note: Warn patients taking hypnotics or sedating antihistamines about additive drowsiness, and about driving. The interaction is pharmacodynamic and dose-related; it is not a reason to withhold the herb but is a reason to start low.
QT-prolonging drugs
Moderate · Potential QT prolongation and arrhythmia risk · Evidence level: Possible
Both magnolol and honokiol block the hERG potassium channel in vitro, and their blockade is additive when the two are present together, as they always are in the bark. This is patch-clamp evidence in a heterologous expression system, not a clinical arrhythmia signal, and no case reports of torsades attributable to Hou Po are on record.
Clinical note: Take the concern seriously in patients already on QT-prolonging medication such as sotalol, amiodarone, methadone or macrolides, or with known long QT, hypokalaemia or hypomagnesaemia. For everyone else the in vitro finding does not warrant avoiding a standard course.
CYP1A2 and CYP2C substrates
Moderate · Altered plasma concentrations of substrate drugs · Evidence level: Possible
Honokiol and magnolol modulate rat hepatic CYP1A and CYP2C activity and change the pharmacokinetics of phenacetin and diclofenac in vivo, with the two neolignans acting differently from each other. The work is in rats; human interaction studies have not been done.
Clinical note: Watch for altered effect of theophylline, clozapine, warfarin, phenytoin and NSAIDs when a bark extract is used at concentrated doses over weeks. Species extrapolation is imperfect here, so monitoring the drug rather than avoiding the herb is the proportionate response.
Non-depolarising neuromuscular blocking agents
Theoretical · Potential potentiation of neuromuscular blockade · Evidence level: Theoretical
The bark contains magnocurarine, a quaternary benzylisoquinoline alkaloid structurally analogous to tubocurarine, and Health Canada has warned that magnolia bark contains tubocurarine-related substances capable of causing respiratory paralysis in animals. No human interaction with anaesthetic neuromuscular blockers has been reported, and magnocurarine content in authentic Magnolia officinalis bark is low.
Clinical note: Include Hou Po in the herbal history taken before general anaesthesia and stop it in the standard pre-operative window. The regulatory caution about infants and small children is the more practically relevant point for routine dispensing.
Hou Po Hua (Flos Magnoliae Officinalis, the flower bud of the same species)
Minor · Substitution reduces the delivered dose of the active neolignans · Evidence level: Established
Hou Po Hua is the dried flower bud of Magnolia officinalis and is a separate Pharmacopoeia drug with its own assay and a far lower magnolol and honokiol content than the bark, on the order of a tenth. Because the pinyin names differ by only one syllable and both derive from the same species, the two are occasionally conflated in supply and in reference databases.
Substituting the flower bud for the bark is not toxic, but it under-delivers the constituents the bark's evidence rests on, and the flower is traditionally regarded as a gentler drug for qi stagnation rather than an equivalent of the bark.
Clinical note: Confirm that a supplier's Hou Po is Cortex Magnoliae Officinalis and not Flos Magnoliae Officinalis, and do not read bark studies onto flower-bud products.
Dosage
| Form | Amount | Frequency | Notes |
|---|---|---|---|
| decoction | 3–10 g | Daily | 中国药典 2020 【用法与用量】3~10g。 【性味与归经】苦、辛,温。归脾、胃、肺、大肠经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value. |
Dui yao: classical pairings
Hou Po + Ban Xia半夏
Transforms phlegm and descends counterflow while moving qi and dispersing constraint, dissolving the phlegm-qi knot in the throat.
Plum-pit qi: sensation of something stuck in the throat that cannot be swallowed or coughed up.
Core pair of a classical formula — Ban Xia Hou Po Tang, Jin Gui Yao Lue (Zhang Zhongjing)
Hou Po + Cang Zhu苍术
Dries dampness and moves qi together, relieving the fullness and distention of dampness encumbering the spleen and stomach.
Epigastric and abdominal distention, no appetite, thick greasy tongue coating.
Core pair of a classical formula — Ping Wei San, Taiping Huimin Hejiju Fang
Hou Po + Huang Lian黄连
Clears heat and dries dampness while moving qi, resolving damp-heat obstructing the middle burner.
Damp-heat sudden turmoil disorder with vomiting and diarrhea.
Core pair of a classical formula — Lian Po Yin, Huo Luan Lun (Wang Shixiong)
Hou Po + Xiang Ru香薷
Releasing summer-cold from the exterior combines with transforming dampness and moving qi internally, addressing summertime cold invasion with dampness.
Summer: chills and fever without sweating plus abdominal fullness, nausea or diarrhea.
Core pair of a classical formula — Xiang Ru San, Tai Ping Hui Min He Ji Ju Fang
Hou Po + Xing Ren杏仁
Descend lung qi and transform phlegm to calm wheezing.
Wheezing in an exterior pattern or chronic wheezing with phlegm. Xing Ren is mildly toxic in overdose.
Core pair of a classical formula — Gui Zhi Jia Hou Po Xing Zi Tang, Shang Han Lun (Zhang Zhongjing)
Hou Po + Zhi Shi枳实
Move qi and break up stagnation in the stomach and intestines, relieving distention, fullness and constipation.
Abdominal fullness and pain with constipation from qi stagnation.
Core pair of a classical formula — Hou Po San Wu Tang, Jin Gui Yao Lue (Zhang Zhongjing)
Hou Po + Zi Su Zi紫苏子
Descends lung qi and transforms phlegm while moving qi and calming wheezing, addressing excess above with phlegm-qi counterflow.
Core pair of a classical formula — Su Zi Jiang Qi Tang, Tai Ping Hui Min He Ji Ju Fang
Evidence
Study design on record, not certainty of outcome.
- Randomized controlled trial
- 2
- In vitro / animal
- 3
Effects of Ban-Xia-Hou-Pu-Tang and Western medicine on patients with globus sensation: A randomized controlled trial
Yeh HF, Chu YS, Hwang SJ, Chen FP, Lu YT · Journal of the Chinese Medical Association · 2025 · RCT
Randomized controlled trial · Verified
Randomized controlled trial comparing Ban-Xia-Hou-Pu-Tang against Western medical management in patients with globus sensation, the classical plum-pit qi presentation for which this formula is the standard prescription.
Hou Po is one of five ingredients in the formula, so the trial supports the traditional indication but does not isolate the bark's contribution.
Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial
Kalman DS, Feldman S, Feldman R, Schwartz HI, Krieger DR, Garrison R · Nutrition Journal · 2008 · RCT
Randomized controlled trial · Not yet verified
Pilot double-blind placebo-controlled trial of a proprietary Magnolia officinalis bark and Phellodendron amurense extract in premenopausal women reporting stress-related eating, showing improvement in transient anxiety measures over six weeks.
Small, pilot-scale, industry-linked, and testing a two-herb combination product rather than Hou Po alone; it is among the very few human trials of a magnolia bark extract and should be weighted accordingly.
hERG channel blockade and additive interactions of magnolol and honokiol from Magnolia species
Zhao W, Hao T, Lu H, Jiang C, Xu J, Zhang Z, Stalin A, Zhang X, Pan L, Xu J · Toxicology Letters · 2026 · in vitro
In vitro / animal · Not yet verified
Patch-clamp study finding that magnolol and honokiol each block the hERG potassium channel and that their effects are additive when combined, which matters because the bark always delivers both together.
In vitro only; it establishes a cardiac liability signal for the isolated neolignans rather than a clinical arrhythmia risk for the crude drug.
Modulation of Rat Hepatic CYP1A and 2C Activity by Honokiol and Magnolol: Differential Effects on Phenacetin and Diclofenac Pharmacokinetics In Vivo
Kim SB, Kim KS, Ryu HM, Hong SH, Kim BK, Kim DD, Park JW, Yoon IS · Molecules · 2018 · animal
In vitro / animal · Verified
In rats, honokiol and magnolol altered hepatic CYP1A and CYP2C activity and changed the pharmacokinetics of the probe substrates phenacetin and diclofenac, with the two neolignans producing different effects.
This is the principal experimental basis for the CYP-mediated interaction caution; it has not been reproduced in humans.
Studies on the Alkaloids of the Bark of Magnolia officinalis: Isolation and On-line Analysis by HPLC-ESI-MSn
Yan R, Wang W, Guo J, Liu H, Zhang J, Yang B · Molecules · 2013 · in vitro
In vitro / animal · Not yet verified
Analytical characterisation of the alkaloid fraction of Magnolia officinalis bark, identifying magnocurarine, magnoflorine, tembetarine and related isoquinoline alkaloids by HPLC-ESI-MSn.
Documents that the curare-like alkaloid is genuinely present in the bark, alongside the much better known neolignans.
Safety
Contraindications
Its use is cautious in patients with qi deficiency and fluid consumption or pregnant women.
Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 131–133.
Cultural and historical
Shen Nong Ben Cao Jing · Han dynasty, compiled c. 200 BCE to 200 CE
Shang Han Lun (Treatise on Cold Damage), Zhang Zhongjing · Eastern Han dynasty, c. 200 to 210 CE
Jin Gui Yao Lue (Essential Prescriptions of the Golden Cabinet), Zhang Zhongjing · Eastern Han dynasty, c. 220 CE
Ming Yi Bie Lu (Miscellaneous Records of Famous Physicians) · Attributed to Tao Hongjing, c. 500 CE
Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen · Ming dynasty, 1578, printed 1596
References
- Poivre M, Duez P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. Journal of Zhejiang University-SCIENCE B. 2017 doi:10.1631/jzus.B1600299
- Sarrica A, Kirika N, Romeo M, Salmona M, Diomede L. Safety and Toxicology of Magnolol and Honokiol. Planta Medica. 2018 doi:10.1055/a-0642-1966
- Luo H, Wu H, Yu X, Zhang X, Lu Y, Fan J, Tang L, Wang Z. A review of the phytochemistry and pharmacological activities of Magnoliae officinalis cortex. Journal of Ethnopharmacology. 2019 doi:10.1016/j.jep.2019.02.041
- Yuan Y, Zhou X, Wang Y, Wang Y, Teng X, Wang S. Cardiovascular Modulating Effects of Magnolol and Honokiol, Two Polyphenolic Compounds from Traditional Chinese Medicine-Magnolia Officinalis. Current Drug Targets. 2020 doi:10.2174/1389450120666191024175727
Look-alike names
- Hu Po琥珀